Cargando…
Pediatric pharmacovigilance in an institute of national importance: Journey has just begun
OBJECTIVE: The objective of this study is to determine the nature and severity of adverse drug reactions (ADRs) in pediatric patients. MATERIALS AND METHODS: In this retrospective cohort study, we extracted the data from all the available pediatric ADR forms submitted to ADR monitoring center (AMC)...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830850/ https://www.ncbi.nlm.nih.gov/pubmed/29515280 http://dx.doi.org/10.4103/ijp.IJP_256_17 |
_version_ | 1783303078244515840 |
---|---|
author | Sharma, Pramod Kumar Misra, Arup Kumar Gupta, Neeraj Khera, Daisy Gupta, Ajay Khera, Pushpinder |
author_facet | Sharma, Pramod Kumar Misra, Arup Kumar Gupta, Neeraj Khera, Daisy Gupta, Ajay Khera, Pushpinder |
author_sort | Sharma, Pramod Kumar |
collection | PubMed |
description | OBJECTIVE: The objective of this study is to determine the nature and severity of adverse drug reactions (ADRs) in pediatric patients. MATERIALS AND METHODS: In this retrospective cohort study, we extracted the data from all the available pediatric ADR forms submitted to ADR monitoring center (AMC) from May 2014 to December 2016. The data including nature, frequency, causality (World Health Organization [WHO] causality scale), and the severity (Hartwig and Siegel scale for severity) of ADR were extracted. We also assessed the preventability of the event on modified Schumock and Thornton scale of ADR preventability. RESULTS: There were a total of 20 pediatric ADRs reported during this period. Nearly two-thirds of the ADRs occurred in patients who were receiving multiple drugs (polytherapy). Antimicrobial agents were the most commonly implicated drugs. The most common ADRs were skin rash (maculopapular, erythematous, and urticaria, itching, etc.). The severity and preventability scales indicated that most reactions (18/20) were moderate in nature and all were preventable. Four reactions were “certainly” and ten ADRs were “probably” related to the suspected drug as determined by the WHO causality assessment. CONCLUSION: Frequency of ADR increased with number of medications patient was receiving. Health-care providers (HCPs) involved in the care of children must be aware of this fact and should use additional drugs when absolutely necessary. They should be involved in pharmacovigilance program by exchanging and updating each other through sharing constructive information, communication, and education concerning the appropriate use of drugs in children. Pediatric pharmacovigilance is the need of the hour and should be given utmost importance for monitoring the safety of drugs in children. Motivating HCPs for voluntary reporting of ADRs for preventing the morbidity and mortality in this vulnerable population could be of immense importance. |
format | Online Article Text |
id | pubmed-5830850 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-58308502018-03-07 Pediatric pharmacovigilance in an institute of national importance: Journey has just begun Sharma, Pramod Kumar Misra, Arup Kumar Gupta, Neeraj Khera, Daisy Gupta, Ajay Khera, Pushpinder Indian J Pharmacol Research Article OBJECTIVE: The objective of this study is to determine the nature and severity of adverse drug reactions (ADRs) in pediatric patients. MATERIALS AND METHODS: In this retrospective cohort study, we extracted the data from all the available pediatric ADR forms submitted to ADR monitoring center (AMC) from May 2014 to December 2016. The data including nature, frequency, causality (World Health Organization [WHO] causality scale), and the severity (Hartwig and Siegel scale for severity) of ADR were extracted. We also assessed the preventability of the event on modified Schumock and Thornton scale of ADR preventability. RESULTS: There were a total of 20 pediatric ADRs reported during this period. Nearly two-thirds of the ADRs occurred in patients who were receiving multiple drugs (polytherapy). Antimicrobial agents were the most commonly implicated drugs. The most common ADRs were skin rash (maculopapular, erythematous, and urticaria, itching, etc.). The severity and preventability scales indicated that most reactions (18/20) were moderate in nature and all were preventable. Four reactions were “certainly” and ten ADRs were “probably” related to the suspected drug as determined by the WHO causality assessment. CONCLUSION: Frequency of ADR increased with number of medications patient was receiving. Health-care providers (HCPs) involved in the care of children must be aware of this fact and should use additional drugs when absolutely necessary. They should be involved in pharmacovigilance program by exchanging and updating each other through sharing constructive information, communication, and education concerning the appropriate use of drugs in children. Pediatric pharmacovigilance is the need of the hour and should be given utmost importance for monitoring the safety of drugs in children. Motivating HCPs for voluntary reporting of ADRs for preventing the morbidity and mortality in this vulnerable population could be of immense importance. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5830850/ /pubmed/29515280 http://dx.doi.org/10.4103/ijp.IJP_256_17 Text en Copyright: © 2018 Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Research Article Sharma, Pramod Kumar Misra, Arup Kumar Gupta, Neeraj Khera, Daisy Gupta, Ajay Khera, Pushpinder Pediatric pharmacovigilance in an institute of national importance: Journey has just begun |
title | Pediatric pharmacovigilance in an institute of national importance: Journey has just begun |
title_full | Pediatric pharmacovigilance in an institute of national importance: Journey has just begun |
title_fullStr | Pediatric pharmacovigilance in an institute of national importance: Journey has just begun |
title_full_unstemmed | Pediatric pharmacovigilance in an institute of national importance: Journey has just begun |
title_short | Pediatric pharmacovigilance in an institute of national importance: Journey has just begun |
title_sort | pediatric pharmacovigilance in an institute of national importance: journey has just begun |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830850/ https://www.ncbi.nlm.nih.gov/pubmed/29515280 http://dx.doi.org/10.4103/ijp.IJP_256_17 |
work_keys_str_mv | AT sharmapramodkumar pediatricpharmacovigilanceinaninstituteofnationalimportancejourneyhasjustbegun AT misraarupkumar pediatricpharmacovigilanceinaninstituteofnationalimportancejourneyhasjustbegun AT guptaneeraj pediatricpharmacovigilanceinaninstituteofnationalimportancejourneyhasjustbegun AT kheradaisy pediatricpharmacovigilanceinaninstituteofnationalimportancejourneyhasjustbegun AT guptaajay pediatricpharmacovigilanceinaninstituteofnationalimportancejourneyhasjustbegun AT kherapushpinder pediatricpharmacovigilanceinaninstituteofnationalimportancejourneyhasjustbegun |